Medicine Safety Tips for Consumers: New Tool Developed by Great Plains QIN

Medicine Safety Tips for Consumers: New Tool Developed by Great Plains QIN

In an effort to enhance medication safety and empower individuals in their healthcare journey, the Great Plains QIN team has developed a tool that provides guidance on how to be smart and safe when it comes to taking medicines. Access Medicine Safety Tips for...
Q-Tips For Your Ears I Five New Episodes

Q-Tips For Your Ears I Five New Episodes

Looking for health care information and quality resources? We added a few more episodes to our podcast series: Q-Tips For Your Ears. This podcast is designed for everyone – healthcare professionals, patients and family members; sharing basic healthcare information on...
June 2023 Calendar of Events

June 2023 Calendar of Events

Below is a compilation of Great Plains Quality Innovation Network’s education offerings for June 2023. With a focus on improving patient outcomes and advancing the field of healthcare, we have quite a few exciting opportunities for healthcare professionals and...
Effectively Integrating Substance Use Disorder Services into Primary Care – May 25, 2023

Effectively Integrating Substance Use Disorder Services into Primary Care – May 25, 2023

Thursday, May 25 |  10:00 am – 2:30 pm CT Clinical staff serving American Indian & Alaska Native people are invited to participate in the Effectively Integrating Substance Use Disorder (SUD) Services into Primary Care virtual training. Learn more. This...
GPQIN Webinar: Break the Chain of Nicotine Dependence | May 23, 2023

GPQIN Webinar: Break the Chain of Nicotine Dependence | May 23, 2023

May 23, 2023 | 3:00 – 4:00 pm CT Chronic nicotine use can increase sensitivity to pain and decrease pain tolerance over time. Nicotine has been found to interfere with the normal functioning of pain receptors in the brain, leading to alterations in pain processing and...
Opioid Prescribing Updated, Adverse Reactions Flagged

Opioid Prescribing Updated, Adverse Reactions Flagged

The FDA has made several updates to its opioid prescribing information, including new warnings about the possibility for increased pain, which can lead to dangerous adverse reactions, such as respiratory depression. Visit the FDA site for updates on prescribing...
Biden-⁠Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States

Biden-⁠Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States

Xylazine’s growing role in overdose deaths nationwide prompts Administration to make this designation for the first time in U.S. history. Access the White House Brief Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), has...